Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Deadly stomach infection rising in community settings, Mayo Clinic study finds

Deadly stomach infection rising in community settings, Mayo Clinic study finds

October 27, 2009

ROCHESTER, Minn. - Mayo Clinic researchers have found that a sometimes deadly stomach bug, Clostridium difficile, (http://www.mayoclinic.org/c-difficile/) is on the rise in outpatient settings. Clostridium difficile is a serious bacteria that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. These findings were presented today at the 2009 American College of Gastroenterology (ACG) Annual Meeting in San Diego.

Clostridium difficile, often called C. difficile or "C. diff", is a bacterium that is resistant to some antibiotics and is most often contracted by the elderly in hospitals and nursing homes.




"Recent reports have shown increasing incidence and severity of C. difficile infection - especially in the older population," says Darrell Pardi, M.D., Mayo Clinic gastroenterologist and senior author on the study. "Our study examines why the cases are on the rise and who is getting the infection."

In this population-based study, researchers studied 385 cases of C. difficile bacterial infection from 1991-2005 to determine how many cases were hospital-acquired versus community-acquired infections. Of the cases, 192 were hospital-acquired and 35 were residents of nursing homes. Of these hospital-acquired cases, the median age of infection was 72 years; in contrast, 158 cases were community-acquired and the median age was 50 years. Thirty-five percent of the hospital infections had a severe illness compared to 22 percent of community infections who had a severe illness.

The patients with community-acquired infection were also less likely than the hospital-acquired group to have been exposed to antibiotics before their infection. Thus, many of the community-acquired infections lacked the traditional risk factors for infection, namely recent hospitalization and exposure to antibiotics.

There were no differences between community- and hospital-acquired infections in terms of what patients were treated with (primarily metronidazole), response rates, or recurrence rates after treatment.

"We are seeing more cases of C. difficile in the community, but they tend to be less severe and in a younger population," says Dr. Pardi. "The growing incidence of C. difficile infection in both inpatient and outpatient settings could be linked to the increasing usage of antibiotics and to the possibility that C. difficile may be getting resistant to some of our newer antibiotics."

There are hundreds of kinds of bacteria found normally in the intestines. Many play beneficial roles in the body. When a patient takes an antibiotic to treat an infection, it often destroys beneficial bacteria as well as the bacteria that are causing the illness. Without enough healthy bacteria, dangerous pathogens such as C. difficile can quickly grow out of control. Once it takes hold, C. difficile can produce two virulent toxins that attack the lining of the intestine.

"Doctors have gotten better at spotting C. difficile in hospitals and nursing homes; however, now doctors and patients need to be more aware that you can get this infection as an outpatient and that a case of diarrhea or abdominal cramps at home could become serious," says Dr. Pardi.

According to the Centers for Disease Control and Prevention, each year in the United States, C. difficile is responsible for tens of thousands of diarrhea cases and at least 5,000 deaths.

Mayo Clinic



Related Clostridium Difficile Current Events and Clostridium Difficile News Articles Clostridium Difficile Current Events and Clostridium Difficile News RSS Clostridium Difficile Current Events and Clostridium Difficile News RSS
Commentary warns of unexpected consequences of proton pump inhibitor use in reflux disease
Despite being highly effective and beneficial for many patients, unexpected consequences are emerging in patients who are prescribed proton pump inhibitors (PPIs) for reflux diseases.

Eating right, not supplements, is best at keeping your good bacteria healthy, dietitian says
Healthy eating, not supplements, is the best way to keep the good bacteria in your gut healthy, says a dietitian and researcher.

Structure of antibiotic ramoplanin reveals promising mechanism
With the "last resort" antibiotic Vancomycin now plagued by the first signs of bacterial resistance, a scientific collaboration centered at Duke University has identified how a candidate successor antibiotic known as Ramoplanin A2 can kill pathogenic bacteria by interrupting how they form their cell membranes.

Antibiotics take toll on beneficial microbes in gut
It's common knowledge that a protective navy of bacteria normally floats in our intestinal tracts. Antibiotics at least temporarily disturb the normal balance.

Newly discovered reactions from an old drug may lead to new antibiotics
A mineral found at health food stores could be the key to developing a new line of antibiotics for bacteria that commonly cause diarrhea, tooth decay and, in some severe cases, death.

Doctors identify patients at high risk of C. difficile
Doctors have developed and validated a clinical prediction rule for recurrent Clostridium difficile (C. difficile) infection that was simple, reliable and accurate, and can be used to identify high-risk patients most likely to benefit from measures to prevent recurrence. Their findings appear in a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

Hospital infection control strategies for antibiotic-resistant organisms
Hand-washing, a clean environment, appropriate infection barriers and early identification of patients at high risk of colonization with a transmissible microorganism remain the essential measures to prevent and control infection.

What makes C-Diff superbug deadly?
A major breakthrough about the potentially deadly superbug Clostridium difficile (C-diff) could lead to new ways to combat the bacterium, according to a study to be published March 1 in the journal Nature.

Monash scientists debug superbug
An international team of scientists, led by Monash University researchers, has uncovered the workings of a superbug that kills elderly hospital patients worldwide - a discovery that has the potential to save lives and health care systems billions of dollars each year.

Is re-emerging superbug the next MRSA?
Loyola physicians warn little-known bacteria Clostridium difficile next emerging disease threat, killing 1,000s in the United State.
More Clostridium Difficile Current Events and Clostridium Difficile News Articles
Bacteria for Breakfast: Probiotics for Good Health

Bacteria for Breakfast: Probiotics for Good Health
by Kelly Dowhower Karpa, PhD, RPh (Author)

Although in Western society the beneficial aspects of bacteria have been increasingly minimized, we actually need bacteria in our digestive tracts for good health. This resource explains, to laymen and physicians, how probiotics support immune function, prevent urogenital infections, and maintain good gastrintestinal health.

  Clostridium Difficile Test (25 per Pack)
by Marion Scientific

A 20 minute latex agglutination test for C. difficile associated diarrhea, 5 minutes hands on time, requires no instrument, excellent screening tes for stool specimenst, sensitivity found to be from 92 to 95%, negative predictive value 97 to 98%, controls included, performs 25 patient tests.

Giantmicrobes C. Diff Clostridium Difficile [Toy]

Giantmicrobes C. Diff Clostridium Difficile [Toy]
by Giantmicrobes

Giant Microbes are soft, cute, durable, well made, educational, and just a lot of fun too! Each 5-to-7 inch doll is accompanied by an image of the real microbe it represents, as well as information about the microbe. Give it up for C. Diff, hospital's notorious gangsta.

Meridian Immunocard Toxins A & B Kit, 50 Tests

Meridian Immunocard Toxins A & B Kit, 50 Tests
by Meridian Bioscience

Features of the Meridian Immunocard Toxins A & B Kit: Membrane EIA single test for the qualitative detection of Clostridium difficile Toxins A and B in Stool Specimens. High sensitivity: both Toxin A and Toxin B are detected. Rapid detection: results in 15 minutes. No sample pre-treatment required. No reagent dilution required. Easy and single test procedure. Internal control of the procedure on each card. Kit Components: Test cards, specimen diluent, enzyme conjugate, positive control, wash reagent, substrate reagent, transfer pipettes. The product referenced on this detail page is sold be 50/bx.

Clostridium difficile (Current Topics in Microbiology and Immunology)

Clostridium difficile (Current Topics in Microbiology and Immunology)
by K. Aktories (Editor), T.D. Wilkins (Editor)

Clostridium difficile has been recognized as the cause of a broad spectrum of enteric disease ranging from mild antibiotic-associated diarrhea to pseudomembranous colitis. This volume gives new insights into the microbiology, diagnostics and epidemiology of Clostridium difficile and describes recent strategies in treatment of diseases caused by this agent. Main parts of the volume are devoted to Clostridium difficile toxins A and B which are the major virulence factors. The molecular biology, biochemistry, pharmacology and cell biology of these toxins which are the prototypes of a new family of large clostridial cytotoxins is described in great detail. Clostridium difficile toxins act as glucosyltransferases to inactivate small GTP-binding proteins of the Rho family which are involved in...

  Guide to the Elimination of Clostridium Difficile
by Ruth Carrico (Author)



  Clostridium Difficile: Its Role in Intestinal Disease
by Author Unknown (Author)

Despite the tremendous progress made during the last few years in understanding the pathogenesis, epidemiology, diagnosis, and treatment of Clostridium difficile-associated intestinal disease, many extremely important and fundamental questions remain to be answered. The objectives of this book are to summarize the available information regarding Clostridium difficile and its role in intestinal disease and to serve as a basis for future investigations in this challenging area.
Clostridium difficile: its role in Intestinal Disease. An excellent volume that should appeal not only to the devotee of C difficile but to all gastroenterologists and microbiologists, this will not languish on my library shelves like so many other books I have reviewed. It will be regularly thumbed. --R.H....

  Fecal transfer cures relapsing C. diff infection.(GASTROENTEROLOGY)(clostridium difficile): An article from: Internal Medicine News
by Miriam E. Tucker (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on January 1, 2009. The length of the article is 985 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Fecal transfer cures relapsing C. diff infection.(GASTROENTEROLOGY)(clostridium difficile)
Author: Miriam E. Tucker
Publication: Internal Medicine News (Magazine/Journal)
Date: January 1, 2009
Publisher: International Medical News Group
Volume: 42 Issue: 1 Page: 24(1)

Distributed by Gale, a part of Cengage...

  Clostridium difficile (Methods in Molecular Biology)
by Peter Mullany (Editor), Adam P. Roberts (Editor)

This book reviews the state of the art of methods available for the molecular analysis and investigation of virulence of the important human pathogen Clostridium difficile.



  Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003 (1).(RESEARCH): An article from: Emerging Infectious Diseases
by L. Clifford McDonald (Author), Maria Owings (Author), Daniel B. Jernigan (Author)

This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on March 1, 2006. The length of the article is 5384 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003 (1).(RESEARCH)
Author: L. Clifford McDonald
Publication: Emerging Infectious Diseases (Magazine/Journal)
Date: March 1, 2006
Publisher: Thomson Gale
Volume: 12 Issue: 3 Page: 409(7)

Distributed by Thomson...

© 2009 BrightSurf.com